Further progress in the treatment of multiple myeloma.

dc.contributor.authorMalik, Prabhat Singh
dc.contributor.authorKumar, Lalit
dc.date.accessioned2012-06-15T09:19:43Z
dc.date.available2012-06-15T09:19:43Z
dc.date.issued2009-01
dc.identifier.citationMalik Prabhat Singh, Kumar Lalit. Further progress in the treatment of multiple myeloma. National Medical Journal of India. 2009 Jan-Feb; 22(1): 25-27.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/139035
dc.language.isoenen_US
dc.source.urihttps://www.nmji.in/archives/Volume-22/Issue-1/PDF-volume-22-issue-1/Volume-22-issue-1-Select-Sumry3.pdfen_US
dc.subject.meshAntineoplastic Agents --therapeutic use
dc.subject.meshAntineoplastic Agents, Alkylating --therapeutic use
dc.subject.meshAntineoplastic Agents, Hormonal --therapeutic use
dc.subject.meshBoronic Acids --therapeutic use
dc.subject.meshHumans
dc.subject.meshIndia
dc.subject.meshMelphalan --therapeutic use
dc.subject.meshMultiple Myeloma --drug therapy
dc.subject.meshMultiple Myeloma --mortality
dc.subject.meshPrednisone --therapeutic use
dc.subject.meshPyrazines --therapeutic use
dc.titleFurther progress in the treatment of multiple myeloma.en_US
dc.typeArticleen_US
Files